Manipal Hospitals has announced its financial results for the second quarter of FY27, reporting a 21.6 per cent increase in profit after tax (excluding exceptional items) to ₹380.2 crore alongside a 37.3 per cent growth in operational revenue. The period also saw expansions in bed capacity and increases in inpatient and outpatient volumes.

Healthcare provider Manipal Hospitals has reported its financial and operational performance for the second quarter of FY27, registering a 21.6 per cent year-on-year increase in profit after tax (PAT), excluding exceptional items, to reach ₹380.2 crore.

However, PAT including exceptional items declined by 10.3 per cent to ₹285 crore during the quarter, compared to ₹317.8 crore recorded in Q2 FY26. Revenue from operations for the quarter rose by 37.3 per cent year-on-year to ₹3,399.4 crore.

Operational metrics indicated an increase in patient footfalls. Inpatient volumes grew by 35 per cent to approximately 169,000, while outpatient volumes increased by 27.2 per cent to about 1.74 million. Hospital occupancy improved by 160 basis points year-on-year to 70.1 per cent, backed by an average operational capacity of 7,331 beds and an average length of stay of 2.8 days.

The company stated that, excluding the post-tax interest of ₹75 crore on non-convertible debentures (NCDs) raised for the Sahyadri acquisition in Q2 FY27, PAT stood at approximately ₹455 crore. For the first half of FY27, after excluding ₹165 crore in such interest, PAT was approximately ₹804 crore. These figures represented year-on-year growth rates of 45.6 per cent and 37.4 per cent, respectively.

On a consolidated basis, the average revenue per operating bed (ARPOB) remained steady at ₹70,600 per day. However, when excluding Sahyadri, the ARPOB for Q2 and H1 FY27 stood at ₹76,600 and ₹76,900 per day respectively, marking a year-on-year growth of 8.5 per cent and 8.6 per cent.

Capacity expansion continued during the quarter with the launch of a 300-licensed-bed hospital in Electronic City, Bengaluru. This addition brought Manipal Hospitals' total licensed bed capacity to 13,440 as of September 30, 2026.

Speciality-wise, oncology revenue led growth during H1 FY27 with a 51 per cent year-on-year increase. This was followed by neurosciences at 47 per cent, orthopaedics at 44 per cent, cardiac sciences at 39 per cent, renal sciences at 38 per cent, and gastroenterology at 36 per cent.

Dilip Jose, Managing Director and CEO of Manipal Hospitals, commented on the results, noting that the quarter's performance was driven by patient volumes. He stated that improved capacity utilisation, particularly in high-acuity specialities, remained a primary growth driver while the organisation maintains its focus on clinical capabilities, operational performance, and integrated healthcare delivery.

"The financial results of Manipal Hospitals highlight the importance of volume-led growth and high-acuity capacity utilisation in the healthcare sector. Managing large-scale expansions alongside strategic acquisitions requires robust operational integration to balance financing costs and maintain core profitability. This performance demonstrates how sustained patient volume and specialisation can drive revenue expansion in established healthcare institutions." — Dr. Shishir Gupta, Founder & CEO, StartupLanes

Recent StartupLanes Articles

Browse through our 30 latest publications on venture capital, startups, and angel investing.